Krukenberg Tumor: Clinical Trials

2 trials for Krukenberg Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 1, Terminated 1

Follow Krukenberg Tumor: new trials by email Literature Review of Krukenberg Tumor trials Research Report on Krukenberg Tumor

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
ELU001 - Ovarian Cancer, Ovarian Neoplasms
Phase 1 / Phase 2TerminatedElucida Oncology792021-09-132024-08-07
Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients
iv injection of ICG - Ovarian Cancer, Peritoneal Carcinomatosis
Phase 1 / Phase 2CompletedJules Bordet Institute102013-03-012014-10-15

Narrower conditions

Ovarian Neoplasms (2)  ·  Carcinoma (1)  ·  Carcinoma, Endometrioid (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Ovarian Diseases (1)  ·  Peritoneal Neoplasms (1)  ·  Recurrence (1)  ·  Uterine Diseases (1)

Broader conditions

Adenocarcinoma (2)  ·  Adnexal Diseases (2)  ·  Carcinoma, Signet Ring Cell (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Cystic, Mucinous, and Serous (2)

Sponsors

Elucida Oncology (1)  ·  Jules Bordet Institute (1)

Countries

Belgium (1)  ·  United States (1)

Top investigators

Gabriel Liberale, MD (1)  ·  Isabelle Veys, MD (1)